Word: hoechst
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...middle, until recently, was the drug's producer, France's Roussel Uclaf. Its corporate parent, Germany's huge Hoechst chemical company, feared a pro-life boycott of its American products if it allowed RU 486 to be marketed in the U.S. And Yorkin threatened a pro-choice boycott if it didn't. In the face of this dilemma and some badgering by the FDA, the company did what a typically cautious multinational would: it passed its burden (or tried to, anyway) onto the shoulders of someone else, in this case the nonprofit Population Council...
...case, the political debate will certainly make it more difficult to find an American company willing to distribute the drug. After the pill appeared in France, opponents sent 1.5 million critical postcards to Hoechst's U.S. subsidiary, Hoechst Celanese, and they will inevitably call a boycott against all products of any company that gets into the RU 486 business. And that's just the first volley. "Do you think the pharmaceutical corporate executive wants someone picketing in his neighborhood?" asks the Rev. Patrick Mahoney, spokesman for Operation Rescue...
Those political barriers, however, are quickly crumbling. Two days after his Inauguration, President Clinton ordered his Administration to "promote the testing, licensing and manufacturing" of RU 486. Until then, the French manufacturer of the drug, Roussel Uclaf, and its German parent company, Hoechst AG, had steadfastly shied away from becoming involved in the American market for fear of infuriating antiabortion activists. But in April, at the instigation of the U.S. Food and Drug Administration, Roussel announced a compromise: it agreed to license RU 486 to the U.S. Population Council, a nonprofit organization based in New York City, which in turn...
...billion a year, and has just begun to take off. Every potential innovation, whether a new kind of windmill or biodegradable plastic made from plants, is attracting attention from companies in a host of industrial nations. The U.S.'s Du Pont is in a race with Germany's Hoechst and Britain's ICI, among others, to develop replacement chemicals for ozone-destroying chlorofluorocarbons (cfcs). Germany's Siemens is vying with such firms as Amoco in the U.S. and Sanyo in Japan to produce cheap, efficient solar electric cells...
...foes of abortion have managed to keep the French-made drug out of the country. But last week a delegation of American feminists and scientists met in Paris with executives of Roussel Uclaf, the French company that manufactures the drug, and in Frankfurt with officials * from Hoechst AG, Roussel's parent company. The Americans presented a petition signed by 115,000 people urging the distribution of RU 486 in the U.S. American support for the drug has also been growing rapidly among physicians. In June the American Medical Association passed a resolution supporting the "legal availability...